Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

TCR2 Therapeutics Inc. buy BiotechBee

TCR2 Therapeutics Inc.
Start price
€1.31
04.02.23 / 50%
Target price
€3.00
04.02.24
Performance (%)
34.48%
End price
€1.76
05.05.23
Summary
This prediction ended on 05.05.23 with a price of €1.76. With a performance of 34.48% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
TCR2 Therapeutics Inc. - - - -
iShares Core DAX® -0.046% 5.960% 7.403% 65.851%
iShares Nasdaq 100 0.922% 3.693% 28.138% 93.298%
iShares Nikkei 225® 3.014% 6.638% 48.886% 89.079%
iShares S&P 500 -0.359% 2.747% 22.530% 71.942%

According to BiotechBee what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Tcr2 Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 34.48%
Target price 3.000
Change
Ends at 04.02.24

Buy mit Kursziel 3,0

BiotechBee 
0
Report Share
04.02.23
In the thread Trading Tcr2 Therapeutics Inc.
Prediction Buy
Perf. (%) 34.48%
Target price 3.000
Change
Ends at 04.02.24

Buy beendet

BiotechBee 
0
Report Share
05.05.23